Consolidated Statements of Operations (unaudited) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
REVENUES
Product revenue, net	$ 4,850,678	$ 1,218,457
License and contract	3,000	250,000
Total revenues	4,853,678	1,468,457
OPERATING EXPENSES
Cost of products sold	418,470	217,529
Research and development	22,630,577	21,327,434
Selling, general and administrative	15,290,836	16,511,942
Gain on purchase commitment	(1,027,322)	0
Total operating expenses	37,312,561	38,056,905
Loss from operations	(32,458,883)	(36,588,448)
OTHER INCOME (EXPENSE)
Investment income	691,981	29,963
Foreign currency (loss) gain	(429,971)	389,868
Interest expense	(20,013)	(29,682)
Total other income (expense), net	241,997	390,149
Loss before income taxes	(32,216,886)	(36,198,299)
Income tax benefit	4,674,999	0
NET LOSS	$ (27,541,887)	$ (36,198,299)
Basic and diluted net loss per common share	$ (2.53)	$ (3.79)
Weighted average number of common shares outstanding used in computing basic and diluted net loss per common share (Note 1)	10,890,159	9,543,762